On July 14, 2017, BGI Genomics was officially listed and became the 2001st listed company of the Shenzhen Stock Exchange. BGI Genomics is one of the world’s leading genomics tests and research service providers, providing genomics tests and research services for medical institutions, research institutions, enterprises, and institutions through genetic testing and other means. BGI Genomics is committed to helping and accelerating scientific innovation, strengthening the prevention and control of cancer and other genetic diseases, improving diagnostic tools for the rapid diagnosis of infectious disease, and helping the development of precision medicine. Relying on cutting edge bioinformatics pipelines, advanced R&D, high-performance proprietary NGS sequencing technology, mass spectrometers, and underpinned by a decade of commercial experience, BGI Genomics provides its customers with expert and affordable clinical molecular diagnostic solutions and NGS research services.

Da An Gene Co., Ltd. of Sun Yat-sen University relying on the abundant scientific research platform of Sun Yat-sen University, it is a high-tech biomedical enterprise which is led by molecular diagnostic technology and integrates the research and development, production and sales of clinical test reagents and instruments as well as the clinical test service of national chain independent medical laboratories in China.

The company was listed on the Shenzhen Stock Exchange on August 9, 2004, becoming the first listed company among colleges and universities in Guangdong province. It now has more than 797 million shares and a market value of more than 32.9 billion.

The company’s positioning has been changed from a single product to the layout of the entire industrial chain and is committed to exploring a practical model in China’s health undertakings. The company has always been in a leading position in molecular biology technologies, especially the research, development, and application of gene diagnosis technology and reagent products, independently developed the fluorescence quantitative PCR gene diagnosis technology. It has more than a hundred registered medical device certificates, more than 50 CE certificates, and 6 CMDCAS certificates, besides 54 products were identified as high-tech products in Guangdong province, which provides a powerful guarantee for our products entering the domestic and international market. Meanwhile, the company sought for transformation, explored actively, built a value system featuring openness, sharing, cooperation, and win-win results, implemented the open mode of the all-around platform, shared the value of growth, and committed to the health care integration of upstream and downstream suppliers in the field of a strategic goal. At present, over 300 health care enterprises were invested by the company in the incubator model, which completed our layout of the whole industry chain, and we hope to make our contribution to the health industry in China.

In recent years, the company has undertaken many national projects and won awards, such as the national “863” project, “973” project, “ninth five-year plan”, “tenth five-year plan”, and “eleventh five-year plan”.

Maccura Biotechnology Co., Ltd. is a professional enterprise to research and manufacture clinical IVD products.  Founded in 1994, Maccura is a hi-tech enterprise certified by related national departments, focusing on the research, manufacture, marketing, and services of IVD products. It has passed the certification of CMD ISO13485, CQC ISO14001, TUV ISO13485, as well as the CE certification for some products. Maccura became the first Chinese enterprise member of IFCC in 2010 and been certified by CNAS in 2013. In 2015, the reference system department of Maccura had been the first enterprise laboratory in China to enter the JCTLM list and become the cooperation member of IRMM to undertake the assignment for international reference materials.

Maccura has a world-class R&D, manufacture, and operation team, have completed the layout of the whole industrial chain from biological raw materials, medical laboratory products to professional services, and have the systematic ability to research and manufacture IVD instruments, reagents, calibrators and control materials. Our products have covered platforms of biochemistry, immunoassay, POCT, hematology, molecular diagnosis, and pathology, and could meet more than 90% requirements of medical labs with the product integration.

Maccura has closely cooperated with domestic and international R&D institutions, established a special innovation system by introducing advanced devices for R&D, manufacture, and testing. Meanwhile, we have also cooperated with advanced social units, labs, and individuals to establish an innovative open lab for laboratory medicine.

With rich experience in marketing and channel management, Maccura provides distributors and end-users with perfect professional services.

Getein Biotech, Inc. is a Nanjing headquartered and globally operated in-vitro diagnostic company, specializing in analytical medical devices, point-of-care testing kits for more than 15 years. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. Our broad product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and specialty assays, among many others. 

Our mission to “Pursue Excellence and Deliver Health” means a commitment to keep patients’ well-being in mind. We strive to deliver high-quality, reliable, and affordable point-of-care and diagnostic solutions to professional clinical laboratories, hospitals, and physician offices. Our commitment is backed by our quality first policy, talented team, innovative technology, and accountability attitude.

Getein has over 28,000 square-feet of R&D and manufacturing facilities that follow GMP standards and a 60-acre animal breeding base that complies with government regulation. We have obtained ISO13485:2016, and products are CE Marking. Our Total Quality Control System ensures that quality touches everything we produce.

Talent-oriented Team Getein emphasizes employee talent management, both mentally and physically. We encourage our employees to maximize their talents in developing innovative technologies, reliable products, and satisfactory services by placing our priority on the well-being of every staff member at Getein.